Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer Patients.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Apr 2020
Historique:
received: 13 02 2020
revised: 30 03 2020
accepted: 31 03 2020
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 29 12 2020
Statut: epublish

Résumé

Oxidative stress with subsequent premutagenic oxidative DNA damage has been implicated in colorectal carcinogenesis. The repair of oxidative DNA damage is initiated by lesion-specific DNA glycosylases (hOGG1, NTH1, MUTYH). The direct evidence of the role of oxidative DNA damage and its repair is proven by hereditary syndromes (MUTYH-associated polyposis, NTHL1-associated tumor syndrome), where germline mutations cause loss-of-function in glycosylases of base excision repair, thus enabling the accumulation of oxidative DNA damage and leading to the adenoma-colorectal cancer transition. Unrepaired oxidative DNA damage often results in G:C>T:A mutations in tumor suppressor genes and proto-oncogenes and widespread occurrence of chromosomal copy-neutral loss of heterozygosity. However, the situation is more complicated in complex and heterogeneous disease, such as sporadic colorectal cancer. Here we summarized our current knowledge of the role of oxidative DNA damage and its repair on the onset, prognosis and treatment of sporadic colorectal cancer. Molecular and histological tumor heterogeneity was considered. Our study has also suggested an additional important source of oxidative DNA damage due to intestinal dysbiosis. The roles of base excision repair glycosylases (hOGG1, MUTYH) in tumor and adjacent mucosa tissues of colorectal cancer patients, particularly in the interplay with other factors (especially microenvironment), deserve further attention. Base excision repair characteristics determined in colorectal cancer tissues reflect, rather, a disease prognosis. Finally, we discuss the role of DNA repair in the treatment of colon cancer, since acquired or inherited defects in DNA repair pathways can be effectively used in therapy.

Identifiants

pubmed: 32252452
pii: ijms21072473
doi: 10.3390/ijms21072473
pmc: PMC7177219
pii:
doi:

Substances chimiques

DNA Glycosylases EC 3.2.2.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Grantová Agentura České Republiky
ID : 18-09709S
Organisme : Grantová Agentura České Republiky
ID : 19-10543S
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : 15-27580A
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : NV18/03/00199
Organisme : Univerzita Karlova v Praze
ID : UNCE/MED/006
Organisme : Univerzita Karlova v Praze
ID : Progres Q28/LF1
Organisme : National Sustainability Program I
ID : (NPU I) L01503

Références

J Biol Chem. 1993 Nov 5;268(31):23524-30
pubmed: 8226881
Mol Aspects Med. 2019 Oct;69:2-9
pubmed: 31233770
Eur J Med Chem. 2018 Jan 20;144:582-594
pubmed: 29289883
Free Radic Biol Med. 2006 Aug 1;41(3):388-415
pubmed: 16843820
Cell Mol Immunol. 2011 Mar;8(2):110-20
pubmed: 21278760
PLoS One. 2011 Feb 02;6(2):e16691
pubmed: 21311763
Science. 2019 Feb 15;363(6428):
pubmed: 30765538
Clin Cancer Res. 2012 Nov 1;18(21):5878-87
pubmed: 22966016
Mutat Res. 2008 Feb 1;638(1-2):146-53
pubmed: 17991492
Int J Cancer. 2013 Oct 15;133(8):1765-75
pubmed: 23400628
Cancer Res. 2004 Jul 1;64(13):4411-4
pubmed: 15231648
Mutat Res. 2013 Mar-Apr;743-744:26-32
pubmed: 23253900
Mol Carcinog. 2019 Sep;58(9):1531-1550
pubmed: 31168912
Mutat Res. 2007 May-Jun;635(2-3):118-45
pubmed: 17419091
Carcinogenesis. 2003 Feb;24(2):155-7
pubmed: 12584162
Front Microbiol. 2018 Apr 20;9:774
pubmed: 29731748
Lung Cancer. 2017 Jul;109:52-57
pubmed: 28577950
Mutagenesis. 2019 Dec 19;34(4):341-354
pubmed: 31348825
J Biol Chem. 2017 Sep 22;292(38):15870-15879
pubmed: 28751376
J Cancer Res Clin Oncol. 2012 Sep;138(9):1443-8
pubmed: 22526153
Nat Rev Drug Discov. 2013 Dec;12(12):931-47
pubmed: 24287781
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Mutat Res. 2009 Jan-Feb;681(1):68-79
pubmed: 18755290
Cancer Lett. 2016 Oct 1;380(2):442-6
pubmed: 27424524
Sci Rep. 2017 Jun 29;7(1):4384
pubmed: 28663564
Nucleic Acids Res. 2018 Aug 21;46(14):7169-7178
pubmed: 29917162
J Biol Chem. 2002 Nov 1;277(44):42205-13
pubmed: 12200441
Biomed Pharmacother. 2019 Jan;109:1462-1477
pubmed: 30551398
Environ Mol Mutagen. 2013 Dec;54(9):691-704
pubmed: 24123395
Nat Rev Clin Oncol. 2017 Apr;14(4):235-246
pubmed: 27922044
Eurasian J Med. 2018 Oct;50(3):193-201
pubmed: 30515042
Carcinogenesis. 1986 Nov;7(11):1849-51
pubmed: 3769133
Nat Rev Cancer. 2015 Mar;15(3):166-80
pubmed: 25709118
PLoS One. 2019 Sep 13;14(9):e0217913
pubmed: 31518347
Nucleic Acids Res. 2019 Jan 25;47(2):779-793
pubmed: 30496516
Cell Death Dis. 2019 Jun 4;10(6):434
pubmed: 31164636
Chem Sci. 2019 Jun 27;10(31):7407-7417
pubmed: 31489163
Mutat Res. 2013 Mar-Apr;743-744:12-25
pubmed: 23195996
J Formos Med Assoc. 2019 Mar;118 Suppl 1:S32-S41
pubmed: 30655033
BMC Cancer. 2018 Apr 16;18(1):423
pubmed: 29661172
Clin Cancer Res. 2001 Dec;7(12):4143-8
pubmed: 11751514
Int J Mol Sci. 2019 Dec 03;20(23):
pubmed: 31816862
Carcinogenesis. 2015 Nov;36(11):1299-306
pubmed: 26354780
Transl Cancer Res. 2013 Jun;2(3):
pubmed: 24224145
Mutagenesis. 2012 Mar;27(2):225-32
pubmed: 22294771
PLoS One. 2014 Mar 03;9(3):e90261
pubmed: 24595271
Curr Biol. 2014 May 19;24(10):R453-62
pubmed: 24845678
Sci Rep. 2014 Apr 15;4:4689
pubmed: 24732879
Cancer Med. 2017 Jan;6(1):258-266
pubmed: 27917618
Eur J Nutr. 2012 Apr;51(3):261-79
pubmed: 22362552
Nat Rev Cancer. 2016 Sep;16(9):599-612
pubmed: 27515922
Toxicol Lett. 2009 Oct 8;190(1):41-7
pubmed: 19563869
DNA Repair (Amst). 2019 May;77:18-26
pubmed: 30852368
Nature. 2014 Jan 23;505(7484):559-63
pubmed: 24336217
Free Radic Biol Med. 2002 Jul 15;33(2):192-200
pubmed: 12106815
Nat Rev Cancer. 2012 Dec;12(12):801-17
pubmed: 23175119
Br J Cancer. 2017 Mar 14;116(6):793-801
pubmed: 28141798
Nat Rev Cancer. 2016 Jan;16(1):20-33
pubmed: 26678314
Clin Colorectal Cancer. 2015 Mar;14(1):1-10
pubmed: 25579803
Cancers (Basel). 2017 May 08;9(5):
pubmed: 28481306
Arq Bras Cir Dig. 2017 Apr-Jun;30(2):98-102
pubmed: 29257843
DNA Repair (Amst). 2019 Nov;83:102673
pubmed: 31387777
J Pathol. 2017 May;242(1):10-15
pubmed: 28127763
J Cell Mol Med. 2015 Aug;19(8):1949-55
pubmed: 25858687
Biochemistry. 1990 Jul 31;29(30):7024-32
pubmed: 2223758
DNA Repair (Amst). 2014 Apr;16:66-73
pubmed: 24674629
Cell Mol Life Sci. 2009 Mar;66(6):981-93
pubmed: 19153658
Carcinogenesis. 1993 Feb;14(2):265-8
pubmed: 8382115
Antioxid Redox Signal. 2013 Jun 20;18(18):2409-19
pubmed: 23216312
Gastroenterology. 2015 Oct;149(5):1177-1190.e3
pubmed: 26216840
Free Radic Biol Med. 2019 Feb 1;131:264-273
pubmed: 30552997
Cancer Treat Res. 2014;159:145-66
pubmed: 24114479
Crit Rev Eukaryot Gene Expr. 2014;24(1):15-28
pubmed: 24579667
Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-732
pubmed: 31455888
Mol Carcinog. 2015 Sep;54(9):769-78
pubmed: 24585457
J Pathol. 2018 Feb;244(2):135-142
pubmed: 29105096
Carcinogenesis. 2007 Mar;28(3):657-64
pubmed: 17028303
Cell Rep. 2018 Apr 03;23(1):239-254.e6
pubmed: 29617664
Mutat Res. 2013 May-Jun;745-746:6-15
pubmed: 23618615
Nucleic Acids Res. 2003 Oct 1;31(19):5526-33
pubmed: 14500814
Nucleic Acids Res. 2018 Jan 25;46(2):568-581
pubmed: 29253232
Nat Commun. 2018 Mar 6;9(1):967
pubmed: 29511213
Mod Pathol. 2018 Aug;31(8):1291-1301
pubmed: 29588532
Hum Mutat. 2019 Apr;40(4):472-482
pubmed: 30653782
DNA Repair (Amst). 2018 Dec;72:77-85
pubmed: 30314738
J Clin Oncol. 2015 Sep 10;33(26):2901-7
pubmed: 26261251
Biosci Microbiota Food Health. 2019;38(3):97-104
pubmed: 31384521
Oncol Lett. 2017 Apr;13(4):2161-2168
pubmed: 28454376
Nat Genet. 2019 Jan;51(1):76-87
pubmed: 30510241
Curr Drug Targets. 2018;19(1):21-37
pubmed: 28699513
PLoS One. 2013 Sep 06;8(9):e72091
pubmed: 24039736
Gut. 2017 Apr;66(4):633-643
pubmed: 26992426
Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):659-670
pubmed: 29970888
Oncotarget. 2015 Oct 27;6(33):34069-70
pubmed: 26431160
Sci Rep. 2017 Aug 21;7(1):9001
pubmed: 28827588
Pharmacol Ther. 2020 Feb;206:107447
pubmed: 31756363
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14691-6
pubmed: 20679230
Elife. 2019 Sep 30;8:
pubmed: 31566562
Cold Spring Harb Perspect Biol. 2013 Apr 01;5(4):a012583
pubmed: 23545420
Virchows Arch. 2017 Sep;471(3):329-336
pubmed: 28597080
Oncotarget. 2017 Sep 8;8(43):75767-75777
pubmed: 29088908
Immunity. 2019 Jul 16;51(1):15-26
pubmed: 31315033
Chin J Cancer. 2016 Jan 06;35:4
pubmed: 26738600
Nature. 2012 Aug 9;488(7410):178-84
pubmed: 22797518
Hepatogastroenterology. 2004 May-Jun;51(57):638-42
pubmed: 15143881
Nature. 2011 Jun 15;474(7351):327-36
pubmed: 21677749
Dig Dis Sci. 2015 Mar;60(3):762-72
pubmed: 25492499
Nature. 2014 Apr 10;508(7495):215-21
pubmed: 24695224
Ann Oncol. 2018 Aug 1;29(8):1800-1806
pubmed: 29860358
Mutagenesis. 2019 Oct 12;:
pubmed: 31605533
Dis Markers. 2004;20(4-5):199-206
pubmed: 15528785
Epigenomics. 2014 Apr;6(2):179-91
pubmed: 24811787
Eur J Surg Oncol. 2015 Mar;41(3):300-8
pubmed: 25468456
Trends Cancer Res. 2017;12:111-132
pubmed: 30147278
World J Gastroenterol. 2016 Jan 14;22(2):501-18
pubmed: 26811603
DNA Repair (Amst). 2019 Jan;73:49-54
pubmed: 30448017
Int J Colorectal Dis. 2011 Dec;26(12):1525-30
pubmed: 21695387
Genes Dev. 2018 May 1;32(9-10):658-669
pubmed: 29773556
J Natl Cancer Inst. 2014 Apr 26;106(5):
pubmed: 24771875
Cell Death Dis. 2016 Jun 09;7(6):e2253
pubmed: 27277675
World J Gastroenterol. 2016 Dec 28;22(48):10680-10686
pubmed: 28082821
Mutat Res. 2009 Feb 10;661(1-2):10-7
pubmed: 19022266
Mutat Res Rev Mutat Res. 2015 Jan-Mar;763:212-45
pubmed: 25795122
World J Gastroenterol. 2017 Jul 7;23(25):4548-4558
pubmed: 28740343
Carcinogenesis. 2004 May;25(5):757-63
pubmed: 14729591
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4015-21
pubmed: 15217933
Pharmacogenomics. 2019 Nov;20(17):1225-1233
pubmed: 31691643
N Engl J Med. 2009 Dec 17;361(25):2449-60
pubmed: 20018966
Clin Cancer Res. 2013 Nov 1;19(21):6044-56
pubmed: 24036853
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Mutat Res. 2012 Mar 1;731(1-2):1-13
pubmed: 22155132
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14314-9
pubmed: 23940330
Gut. 2019 Dec;68(12):2129-2141
pubmed: 31366457
Cell Mol Life Sci. 2018 Oct;75(20):3741-3750
pubmed: 30043138
J Clin Invest. 2016 Nov 1;126(11):4219-4236
pubmed: 27760045
Science. 2012 Oct 5;338(6103):120-3
pubmed: 22903521
Cancer Lett. 2007 May 18;250(1):74-81
pubmed: 17081686
World J Gastroenterol. 2016 Mar 28;22(12):3372-80
pubmed: 27022219
Curr Opin Gastroenterol. 2014 Mar;30(2):189-95
pubmed: 24457346
Cell Mol Life Sci. 2009 Mar;66(5):788-99
pubmed: 18979208
Mutat Res. 2012 Aug 1;736(1-2):82-92
pubmed: 22561673
Annu Rev Biochem. 2008;77:313-38
pubmed: 18518823
Mutat Res. 2019 Sep;845:403065
pubmed: 31561886
Cell Death Dis. 2019 Aug 8;10(8):600
pubmed: 31395855
Int J Cancer. 2020 Jan 15;146(2):363-372
pubmed: 31209889
J Natl Cancer Inst. 2012 Nov 21;104(22):1765-9
pubmed: 23104324
FASEB J. 2003 Jul;17(10):1195-214
pubmed: 12832285
Eur J Med Chem. 2019 Nov 15;182:111657
pubmed: 31499361
Mutat Res. 2019 Jul;843:95-110
pubmed: 31421745
Br J Cancer. 2018 Oct;119(7):785-792
pubmed: 30287914
Int J Mol Sci. 2018 Dec 27;20(1):
pubmed: 30591675

Auteurs

Pavel Vodicka (P)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 323 00 Pilsen, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic.

Marketa Urbanova (M)

Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic.

Pavol Makovicky (P)

Department of Biology, Faculty of Education, J Selye University, Bratislavska 3322, 945 01 Komarno, Slovakia.

Kristyna Tomasova (K)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 323 00 Pilsen, Czech Republic.

Michal Kroupa (M)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 323 00 Pilsen, Czech Republic.

Rudolf Stetina (R)

Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.

Alena Opattova (A)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 323 00 Pilsen, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic.

Klara Kostovcikova (K)

Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.

Anna Siskova (A)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic.

Michaela Schneiderova (M)

Department of Surgery, University Hospital Kralovske Vinohrady in Prague, Third Medical Faculty, Charles University, Ruska 87, 100 00 Prague, Czech Republic.

Veronika Vymetalkova (V)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 323 00 Pilsen, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic.

Ludmila Vodickova (L)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 323 00 Pilsen, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH